Digital Transformation for Life Sciences, Pharmaceuticals and BioTech
Pharmaceutical and biotech firms must show control from molecule to market. Routeget connects development, manufacturing, quality and commercial data so launches are on time and compliant.
30+
clients served
$15M+
Savings Delivered
15+ yrs
Serving the Sector
20+
Projects Delivered
Life Sciences, Pharmaceuticals and BioTech: where the market stands today
A fact base for planning. All figures below are third-party research estimates, not Routeget data, and they differ by how each firm defines the market.
Biologics and precision medicine
Biologics, gene and cell therapies and AI-assisted discovery are expanding the sector.
About US$1.65 trillion in pharmaceuticals; US$1.55 to 1.95 trillion in biotechnology
Spherical Insights and Grand View Research size the two markets in these ranges for 2024.
About 5.8% to 15.9% CAGR
Pharmaceuticals grow about 6%, while biotechnology is projected to grow 12% to 16%.
Speed to market and supply reliability
Faster tech transfer and reliable supply decide launch success.
Sources: Spherical Insights; Grand View Research; BioSpace; Precedence Research. Figures vary by publisher and definition; verify before external citation. Estimates retrieved October 2026 and subject to each publisher’s definitions; verify against the publisher before citing externally.
End-to-end digital transformation
Strategy, platform selection, integration and data work delivered as one programme.
Regulated-industry data models
Batch, lot, specification and change records designed for GxP-style environments.
Compliance and audit readiness
Electronic records, approvals and traceability built into daily workflows.
Laboratory and plant integration
Connections between laboratory systems, production, warehouse and finance.
Four pressures that shape life sciences, pharmaceuticals & biotech operations
These are the recurring problems we see when development, manufacturing, quality and commercial operations run on disconnected systems.
Development to manufacturing handover
Process knowledge is lost between development and plant.
Capabilities built for development, manufacturing, quality and commercial operations
Pick the area closest to your priority. Each can be delivered on its own or as part of a wider programme.
Keep controlled records for pharmaceutical and biotech products.
- Formula, specification and master-record management
- Batch records with in-process checks
- Change control and deviation workflows
- Lot genealogy from ingredient to customer
Make audits routine rather than a project.
- Electronic approvals and audit trails
- Supplier qualification and material release
- Complaint, recall and CAPA workflows
- Document and training control
Connect the lab to the plant.
- Sample, test and result tracking by lot
- Stability and retention sample management
- Equipment calibration and maintenance records
- Yield and cost by batch
Plan, ship and sell with control.
- Controlled-temperature and expiry-aware stock
- Serialisation and customer shipment records
- Tender, contract and price management
- Margin by product, market and channel
Two scenarios where connected data changes the day-to-day
These are illustrative scenarios that describe the business objective. They are not customer case studies.
Speeding tech transfer
Process and test data move from development to manufacturing in a structured pack.
Business objective: shorten time to market.
Managing partner manufacturing
Partner stock and batch data are visible with your own.
Business objective: protect supply.
How we approach delivery and evidence outcomes
We do not publish unverified customer figures on industry pages. This is how we make outcomes measurable in an engagement.
Baseline first
We agree the starting measures with you before design, such as time to market, batch right-first-time and supply reliability.
Delivery in stages
Releases are phased by site and process, so each stage is tested against real operations before the next.
Measured against your targets
Dashboards report the baseline measures from go-live, so benefit is judged on your data.
Examples of Routeget engagements can be discussed in a discovery call, subject to client approval for each reference.
Why Routeget for life sciences, pharmaceuticals & biotech
We bring a delivery approach built around the realities of regulated submissions, complex supply chains and launch deadlines.
Lifecycle and compliance depth
We link development, batch and quality records so submissions and audits draw on one dataset.
Integrated, not stitched together
Laboratory, production, quality, warehouse and finance share one data model, so operational and financial records reconcile.
Phased, low-disruption rollout
We plan releases around trial milestones, approvals and patent expiries to protect service levels.
Data you can act on
Analytics are designed with your operations team, so measures reflect how your plants actually run.
Related reading from the Routeget team
Perspectives on the supply chain, data and integration topics behind this industry.
Why Automating our Supply Chain is Crucial to your Business Success
Why supply chain automation matters for service levels, cost and resilience.
The Evolving Landscape of Data Modernization Engineering
Trends in data modernization engineering and how they affect enterprise platforms.
AI attracts a new generation while assisting Argentine small producers and winemakers in competing
How AI is helping small producers compete in demanding markets.
Explore adjacent industry practices
Plan your life sciences, pharmaceuticals & biotech digital foundation with Routeget
Book a 30-minute discovery to walk through your development sites, plants, partners and markets and your priorities with a Routeget industry specialist.
Your details are used only to respond to this enquiry. See our Privacy Policy.
Life Sciences, Pharmaceuticals & BioTech: questions buyers ask us
How do you engage with a life sciences, pharmaceuticals & biotech business?
We usually start with a short discovery and a process review of one product and its lifecycle data. From there we propose a phased scope, which can be fixed-scope for defined releases or a time-and-materials team for ongoing improvement.
Can you support GMP environments?
We support controlled records and audit trails, with validation done under your quality procedures.
Do you support partner manufacturing?
Partner orders, stock and batches are tracked end to end.
Who owns the data and the configuration?
You do. The solution runs in your own environment, and configuration, data models and reports are documented and handed over so your team can maintain them.
How do you approach pricing and timelines?
Pricing and timing follow scope, including the number of products, sites and regulated markets. We share an estimate after discovery, with assumptions and exclusions stated, and we confirm timelines only after reviewing your landscape.